These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 15304070)

  • 1. More on: aspirin resistance.
    Szczeklik A; Undas A
    J Thromb Haemost; 2004 Aug; 2(8):1489. PubMed ID: 15304070
    [No Abstract]   [Full Text] [Related]  

  • 2. Pl(A2) polymorphism of beta(3) integrins is associated with enhanced thrombin generation and impaired antithrombotic action of aspirin at the site of microvascular injury.
    Undas A; Brummel K; Musial J; Mann KG; Szczeklik A
    Circulation; 2001 Nov; 104(22):2666-72. PubMed ID: 11723016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of platelet glycoprotein IIIa polymorphism in the high prevalence of in vitro aspirin resistance in patients with intracoronary stent restenosis.
    Pamukcu B; Oflaz H; Nisanci Y
    Am Heart J; 2005 Apr; 149(4):675-80. PubMed ID: 15990752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reasons for resistance to aspirin in cardiovascular disease.
    Szczeklik A; Musiał J; Undas A
    Circulation; 2002 Nov; 106(22):e181-2; author reply e181-2. PubMed ID: 12451018
    [No Abstract]   [Full Text] [Related]  

  • 5. Aspirin alters the cardioprotective effects of the factor XIII Val34Leu polymorphism.
    Undas A; Sydor WJ; Brummel K; Musial J; Mann KG; Szczeklik A
    Circulation; 2003 Jan; 107(1):17-20. PubMed ID: 12515735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycoprotein IIIA gene (PlA) polymorphism and aspirin resistance: is there any correlation?
    Papp E; Havasi V; Bene J; Komlosi K; Czopf L; Magyar E; Feher C; Feher G; Horvath B; Marton Z; Alexy T; Habon T; Szabo L; Toth K; Melegh B
    Ann Pharmacother; 2005 Jun; 39(6):1013-8. PubMed ID: 15840736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombin generation in myocardial infarction and hypercholesterolemia: effects of aspirin.
    Szczeklik A
    Thromb Haemost; 1995 Jul; 74(1):77-80. PubMed ID: 8578530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No effect of polymorphisms in prothrombotic genes on the risk of myocardial infarction in young adults without cardiovascular risk factors.
    Martini CH; Doggen CJ; Cavallini C; Rosendaal FR; Mannucci PM
    J Thromb Haemost; 2005 Jan; 3(1):177-9. PubMed ID: 15634285
    [No Abstract]   [Full Text] [Related]  

  • 9. Synergism between factor XII -4C>T and factor XIII Val34Leu polymorphisms in fibrinolytic therapy in acute myocardial infarction.
    Hernández-Romero D; Marín F; Lee KW; Roldán V; Caturla J; Corral J; Valdés M; Lip GY; Vicente V; González-Conejero R
    Thromb Haemost; 2010 Sep; 104(3):650-2. PubMed ID: 20589311
    [No Abstract]   [Full Text] [Related]  

  • 10. The genetics of aspirin resistance.
    Goodman T; Sharma P; Ferro A
    Int J Clin Pract; 2007 May; 61(5):826-34. PubMed ID: 17391325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspirin: redundant in users of nonaspirin, nonsteroidal antiinflammatory agents?
    Ray WA; Murray KT
    Am Heart J; 2002 Mar; 143(3):381-2. PubMed ID: 11868040
    [No Abstract]   [Full Text] [Related]  

  • 12. Severity of acute coronary syndrome is predicted by interactions between fibrinogen concentrations and polymorphisms in the GPIIIa and FXIII genes.
    Odeberg J; Freitag M; Odeberg H; Råstam L; Lindblad U
    J Thromb Haemost; 2006 Apr; 4(4):909-12. PubMed ID: 16634768
    [No Abstract]   [Full Text] [Related]  

  • 13. A pharmacogenetic effect of factor XIII valine 34 leucine polymorphism on fibrinolytic therapy for acute myocardial infarction.
    Marín F; González-Conejero R; Lee KW; Corral J; Roldán V; López F; Sogorb F; Caturla J; Lip GY; Vicente V
    J Am Coll Cardiol; 2005 Jan; 45(1):25-9. PubMed ID: 15629368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin as an emergency drug.
    Wynn RL
    Gen Dent; 2009; 57(5):464-6. PubMed ID: 19903635
    [No Abstract]   [Full Text] [Related]  

  • 15. Frequency of genetic polymorphisms of COX1, GPIIIa and P2Y1 in a Chinese population and association with attenuated response to aspirin.
    Li Q; Chen BL; Ozdemir V; Ji W; Mao YM; Wang LC; Lei HP; Fan L; Zhang W; Liu J; Zhou HH
    Pharmacogenomics; 2007 Jun; 8(6):577-86. PubMed ID: 17559347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The thrombin generation is associated with the PIA1/A2 beta3, integrin polymorphism in aspirin-treated patients with coronary artery disease: a role of statins].
    Stepień E; Szułdrzyński K; Branicka A; Stankiewicz E; Pazdan A; Zieliński L; Bozek M; Tomala M; Guzik B; Godlewski J; Pawelec T; Zmudka K
    Pol Arch Med Wewn; 2007; 117(1-2):33-40. PubMed ID: 17642204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction among COX-2, P2Y1 and GPIIIa gene variants is associated with aspirin resistance and early neurological deterioration in Chinese stroke patients.
    Yi X; Wang C; Zhou Q; Lin J
    BMC Neurol; 2017 Jan; 17(1):4. PubMed ID: 28068952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Factor XIII Val34Leu polymorphism and premature myocardial infarction].
    Marín F; Roldán V; Sogor F
    Rev Esp Cardiol; 2002 Oct; 55(10):1106-7. PubMed ID: 12383402
    [No Abstract]   [Full Text] [Related]  

  • 19. Antithrombotic effects of aspirin based on PLA1/A2 glycoprotein IIIa polymorphism in patients with coronary artery disease.
    Dropinski J; Musial J; Sanak M; Wegrzyn W; Nizankowski R; Szczeklik A
    Thromb Res; 2007; 119(3):301-3. PubMed ID: 16675000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspirin resistance.
    Szczeklik A; Musiał J; Undas A; Sanak M
    J Thromb Haemost; 2005 Aug; 3(8):1655-62. PubMed ID: 16102031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.